Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Richard Thistlethwaite
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Physiology
Procedures
Chemicals & Drugs
Concepts & Ideas
Living Beings
Anatomy
Sign-in to see full Profile
Network (preview)
59
Woodle, Steve
48
Newell, Kenneth
35
Bruce, David
34
Millis, Michael
31
Whitington, Peter
26
Stuart, Frank
26
Bluestone, Jeffrey
25
Broelsch, Christoph Erich
25
Piper, JB
21
Josephson, Michelle
21
Cronin, David
12
Hart, John
11
He, Gang
11
Alonso, Estella
9
Baker, AL
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Richard Thistlethwaite (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Ross Lainie Friedman; Thistlethwaite J Richard;
Minors as living solid-organ donors.
Pediatrics 2008;122(2):454-61.
-
2008: Joseph Josh W; Thistlethwaite J Richard; Josephson Michelle A; Ross Lainie Friedman
An empirical investigation of physicians' attitudes toward intrasibling kidney donation by minor twins.
Transplantation 2008;85(9):1235-9.
-
2008: Ross Lainie Friedman; Thistlethwaite J Richard
Potential inefficiency of a proposed efficiency model for kidney allocation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;51(4):545-8.
-
2007: Ross Lainie Friedman; Siegler Mark; Thistlethwaite J Richard
We need a registry of living kidney donors.
The Hastings Center report 2007;37(6):1 p following 48.
-
2006: Ross Lainie Friedman; Zenios Stefanos; Thistlethwaite J Richard
Shared decision making in deceased-donor transplantation.
Lancet 2006;368(9532):333-7.
-
2006: Losanoff Julian E; Harland Robert C; Thistlethwaite J Richard; Garfinkel Marc R; Williams James W; Milner John; Millis J Michael
Omega jejunoduodenal anastomosis for pancreas transplant.
Journal of the American College of Surgeons 2006;202(6):1021-4.
-
2005: Poduval Rajiv D; Kadambi Pradeep V; Josephson Michelle A; Cohn Richard A; Harland Robert C; Javaid Basit; Huo Dezheng; Manaligod Jose R; Thistlethwaite J Richard; Meehan Shane M
Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection.
Transplantation 2005;79(2):228-35.
-
2004: Josephson Michelle A; Schumm L Philip; Chiu May Y; Marshall Cory; Thistlethwaite J Richard; Sprague Stuart M
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
Transplantation 2004;78(8):1233-6.
-
2003: Meehan Shane M; Limsrichamrern Somchai; Manaligod Jose R; Junsanto Tipsuda; Josephson Michelle A; Thistlethwaite J Richard; Haas M
Platelets and capillary injury in acute humoral rejection of renal allografts.
Human pathology 2003;34(6):533-40.
-
2002: Ross Lainie Friedman; Glannon Walter; Josephson Michelle A; Thistlethwaite J Richard
Should all living donors be treated equally?
Transplantation 2002;74(3):418-21; discussion 421-2.
-
2002: Poduval Rajiv D; Meehan Shane M; Woodle E Steve; Thistlethwaite J Richard; Haas Mark; Cronin David C; Vats Abhay; Josephson Michelle A
Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis.
Transplantation 2002;73(7):1166-9.
-
2002: Fisher Jonathan S; Woodle E Steve; Thistlethwaite J Richard
Kidney transplantation: graft monitoring and immunosuppression.
World journal of surgery 2002;26(2):185-93.
-
2001: Szot G L; Zhou P; Rulifson I; Wang J; Guo Z; Kim O; Newel K A; Thistlethwaite J R; Bluestone J A; Alegre M L
Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2001;1(1):38-46.
-
2001: Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre M L; Thistlethwaite J R; Pearson T C; Larsen C P; Newell K A
CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
Transplantation 2001;71(9):1351-4.
-
2001: Zhou P; Szot G; Guo Z; Kim O; He G; Wang J; Grusby M; Newell K; Thistlethwaite J; Bluestone J; Alegre M
Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig.
Transplantation proceedings 2001;33(1-2):214-6.
-
2001: Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
Transplantation and the CD28/CTLA4/B7 pathway.
Transplantation proceedings 2001;33(1-2):209-11.
-
2001: Meehan S M; Domer P; Josephson M; Donoghue M; Sadhu A; Ho L T; Aronson A J; Thistlethwaite J R; Haas M
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
Human pathology 2001;32(2):205-15.
-
2000: Zhou P; Szot G L; Guo Z; Kim O; He G; Wang J; Grusby M J; Newell K A; Thistlethwaite J R; Bluestone J A; Alegre M L
Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5580-7.
-
2000: Thistlethwaite J R; Nashan B; Hall M; Chodoff L; Lin T H
Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group.
Transplantation 2000;70(5):784-90.
-
2000: Grewal H P; Brady L; Cronin D C; Loss G E; Siegel C T; Oswald K; Fisher J S; Bruce D S; Aronson A J; Woodle E S; Millis J M; Thistlethwaite J R; Newell K A
Combined liver and kidney transplantation in children.
Transplantation 2000;70(1):100-5.
-
2000: Szot G L; Zhou P; Sharpe A H; He G; Kim O; Newell K A; Bluestone J A; Thistlethwaite J R
Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival.
Transplantation 2000;69(5):904-9.
-
1999: Woodle E S; Xu D; Zivin R A; Auger J; Charette J; O'Laughlin R; Peace D; Jollife L K; Haverty T; Bluestone J A; Thistlethwaite J R
Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
Transplantation 1999;68(5):608-16.
-
1999: Josephson M A; Chiu M Y; Woodle E S; Thistlethwaite J R; Haas M
Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(3):540-8.
-
1999: Newell K A; He G; Guo Z; Kim O; Szot G L; Rulifson I; Zhou P; Hart J; Thistlethwaite J R; Bluestone J A
Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(5):2358-62.
-
1999: Theriault B R; Thistlethwaite J R; Levisetti M G; Wardrip C L; Szot G; Bruce D S; Rilo H; Li X; Gray G S; Bluestone J A; Padrid P A
Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis).
Transplantation 1999;68(3):331-7.
-
1999: Meehan S M; Siegel C T; Aronson A J; Bartosh S M; Thistlethwaite J R; Woodle E S; Haas M
The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies.
Journal of the American Society of Nephrology : JASN 1999;10(8):1806-14.
-
1999: Haas M; Meehan S M; Josephson M A; Wit E J; Woodle E S; Thistlethwaite J R
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(1):69-84.
-
1999: He G; Kim O S; Thistlethwaite J R; Hart J; Siegel C T; Szot G L; Newell K A
Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.
Transplantation proceedings 1999;31(1-2):1239-41.
-
1999: He G; Hart J; Kim O S; Szot G L; Siegel C T; Thistlethwaite J R; Newell K A
The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
Transplantation 1999;67(1):131-7.
-
1998: He G; Hart J; Thistlethwaite J R; Newell K A
Modified surgical model of paratopic small bowel transplantation in mice.
The Journal of surgical research 1998;80(2):188-93.
-
1998: Woodle E S; Millis J M; So S K; McDiarmid S V; Busuttil R W; Esquivel C O; Whitington P F; Thistlethwaite J R
Liver transplantation in the first three months of life.
Transplantation 1998;66(5):606-9.
-
1998: He G; Hart J; Thistlethwaite J R; Newell K A
Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
Transplantation proceedings 1998;30(6):2592-3.
-
1998: Dachman A H; Newmark G M; Thistlethwaite J R; Oto A; Bruce D S; Newell K A
Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage.
AJR. American journal of roentgenology 1998;171(1):157-63.
-
1998: Arnow P M; Zachary K C; Thistlethwaite J R; Thompson K D; Bova J L; Newell K A
Pathogenesis of early operative site infections after orthotopic liver transplantation.
Transplantation 1998;65(11):1500-3.
-
1998: Bruce D S; Woodle E S; Newell K A; Millis J M; Cronin D C; Loss G E; Grewal H P; Siegel C T; Pellar S; Josephson M A; Thistlethwaite J R
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Transplantation proceedings 1998;30(4):1538-40.
-
1998: Loss G E; Brady L; Grewal H P; Siegel C T; Mead J; Bruce D S; Cronin D C; Woodle E S; Newell K A; Thistlethwaite J R; Millis J M
Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
Transplantation proceedings 1998;30(4):1435-6.
-
1998: Millis J M; Cronin D C; Newell K A; Bruce D S; Woodle E S; Grewal H P; Loss G E; Lissoos T; Conjeevaram H; Schiano T; O'Laughlin R; Charette J; McNaughton M; Baker A L; Thistlethwaite J R
Successful use of tacrolimus for initial rejection episodes after liver transplantation.
Transplantation proceedings 1998;30(4):1407-8.
-
1998: Grewal H P; Thistlethwaite J R; Loss G E; Bruce D S; Siegel C T; Cronin D C; Newell K A; Millis J M; Woodle E S
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.
Transplantation proceedings 1998;30(4):1378-9.
-
1998: Woodle E S; Bluestone J A; Zivin R A; Jolliffe L K; Auger J; Xu D; Thistlethwaite J R
Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.
Transplantation proceedings 1998;30(4):1369-70.
-
1998: Turner C D; Bruce D S; Cronin D C; Loss G E; Grewal H; Siegel C; Millis J M; Newell K A; Davis B; Todo T; Thistlethwaite J R; Woodle E S
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Transplantation proceedings 1998;30(4):1234-5.
-
1998: He G; Hart J; Thistlethwaite J R; Newell K A
Inhibition of intestinal allograft rejection by an anti-CD8 monoclonal antibody is not mediated by depletion alone.
Transplantation proceedings 1998;30(4):1069-70.
-
1998: Newell K A; Millis J M; Bruce D S; Woodle E S; Cronin D C; Loss G; Grewal H; Alonso E M; Dillon J J; Whitington P F; Thistlethwaite J R
An analysis of hepatic retransplantation in children.
Transplantation 1998;65(9):1172-8.
-
1998: Chiu M Y; Sprague S M; Bruce D S; Woodle E S; Thistlethwaite J R; Josephson M A
Analysis of fracture prevalence in kidney-pancreas allograft recipients.
Journal of the American Society of Nephrology : JASN 1998;9(4):677-83.
-
1998: Bruce D S; Woodle E S; Newell K A; Millis J M; Cronin D C; Loss G E; Pellar S; Josephson M A; Thistlethwaite J R
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
Transplantation proceedings 1998;30(2):507-8.
-
1998: Bruce D S; Newell K A; Woodle E S; Cronin D C; Grewal H P; Millis J M; Ruebe M; Josephson M A; Thistlethwaite J R
Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases.
Transplantation proceedings 1998;30(2):270-1.
-
1998: Newell K A; Millis J M; Arnow P M; Bruce D S; Woodle E S; Cronin D C; Loss G E; Grewal H; Lissoos T; Schiano T; Mead J; Thistlethwaite J R
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.
Transplantation 1998;65(3):439-42.
-
1998: Befeler A S; Lissoos T W; Schiano T D; Conjeevaram H; Dasgupta K A; Millis J M; Newell K A; Thistlethwaite J R; Baker A L
Clinical course and management of inflammatory bowel disease after liver transplantation.
Transplantation 1998;65(3):393-6.
-
1997: Levisetti M G; Padrid P A; Szot G L; Mittal N; Meehan S M; Wardrip C L; Gray G S; Bruce D S; Thistlethwaite J R; Bluestone J A
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5187-91.
-
1997: Newell K A; He G; Hart J; Thistlethwaite J R
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice.
Transplantation 1997;64(7):959-65.
-
1997: Woodle E S; Newell K A; Haas M; Bartosh S; Josephson M A; Millis J M; Bruce D S; Piper J B; Aronson A J; Thistlethwaite J R
Reversal of accelerated renal allograft rejection with FK 506.
Clinical transplantation 1997;11(4):251-4.
-
1997: Newell K A; Alonso E M; Kelly S M; Rubin C M; Thistlethwaite J R; Whitington P F
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
The Journal of pediatrics 1997;131(1 Pt 1):98-104.
-
1997: Lee M Y; Finn H A; Lazda V A; Thistlethwaite J R; Simon M A
Bone allografts are immunogenic and may preclude subsequent organ transplants.
Clinical orthopaedics and related research 1997;(340):215-9.
-
1997: Millis J M; Cronin D C; Newell K A; Piper J B; Woodle E S; Bruce D S; Conjeevaram H; Baker A L; Thistlethwaite J R
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
Transplantation proceedings 1997;29(1-2):1549.
-
1997: Millis J M; Cronin D C; Piper J B; Newell K A; Bruce D S; Woodle E S; Davis B; Seaman E; Thistlethwaite J R
Impact of a liberalized donor acceptance policy on liver transplantation.
Transplantation proceedings 1997;29(1-2):484.
-
1997: Newell K A; Alonso E M; Millis J M; Piper J B; Bruce D S; Woodle E S; Cronin D C; Whitington P F; Thistlethwaite J R
Retransplantation for failed hepatic allografts in children.
Transplantation proceedings 1997;29(1-2):442-3.
-
1997: Cronin D C; Alonso E M; Piper J B; Newell K A; Bruce D S; Woodle E S; Whitington P F; Thistlethwaite J R; Millis J M
Biliary complications in living donor liver transplantation.
Transplantation proceedings 1997;29(1-2):419-20.
-
1997: Cronin D C; Bruce D S; Newell K A; Josephson M A; Millis J M; Piper J B; Ruebe M; Kirby M; Thistlethwaite J R; Woodle E S
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Transplantation proceedings 1997;29(1-2):307.
-
1996: Woodle E S; Thistlethwaite J R; Gordon J H
Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
Transplantation proceedings 1996;28(6):3163-4.
-
1996: Whitington P F; Rubin C M; Alonso E M; McKeithan T W; Anastasi J; Hart J; Thistlethwaite J R
Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.
Transplantation 1996;62(10):1516-9.
-
1996: Newell K A; Bruce D S; Cronin D C; Woodle E S; Millis J M; Piper J B; Huss E; Thistlethwaite J R
Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions.
Transplantation 1996;62(9):1353-6.
-
1996: Seaman D S; Newell K A; Piper J B; Bruce D S; Woodle E S; Cronin D C; Alonso E M; Whitington P F; Thistlethwaite J R; Millis J M
Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation.
Transplantation 1996;62(7):1034-6.
-
1996: Woodle E S; Cronin D; Newell K A; Millis J M; Bruce D S; Piper J B; Haas M; Josephson M A; Thistlethwaite J R
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
Transplantation 1996;62(7):906-10.
-
1996: Woodle E S; Thistlethwaite J R; Gordon J H; Laskow D; Deierhoi M H; Burdick J; Pirsch J D; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch G M; Wilkinson A H; Shaffer D; Simpson M A; Freeman R B; Rohrer R J; Mendez R; Aswad S; Munn S R; Wiesner R H; Delmonico F L; Neylan J; Whelchel J
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
Transplantation 1996;62(5):594-9.
-
1996: Millis J M; Seaman D S; Piper J B; Alonso E M; Kelly S; Hackworth C A; Newell K A; Bruce D S; Woodle E S; Thistlethwaite J R; Whitington P F
Portal vein thrombosis and stenosis in pediatric liver transplantation.
Transplantation 1996;62(6):748-54.
-
1996: Woodle E S; Bruce D S; Josephson M; Cronin D; Newell K A; Millis J M; Piper J B; O'Laughlin R; Thistlethwaite J R
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
Clinical transplantation 1996;10(4):389-95.
-
1996: Woodle E S; Bruce D S; Josephson M; Newell K A; Piper J B; Millis J M; Cronin D; Whitman G; Ruebe M; Thistlethwaite J R
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Clinical transplantation 1996;10(4):323-32.
-
1996: Bruce D S; Newell K A; Josephson M A; Woodle E S; Piper J B; Millis J M; Seaman D S; Carnrike C L; Huss E; Thistlethwaite J R
Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year.
Transplantation 1996;62(4):451-6.
-
1996: Newell K A; Alonso E M; Whitington P F; Bruce D S; Millis J M; Piper J B; Woodle E S; Kelly S M; Koeppen H; Hart J; Rubin C M; Thistlethwaite J R
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Transplantation 1996;62(3):370-5.
-
1996: Bruce D S; Newell K A; Woodle E S; Millis J M; Piper J B; Huss E; Thistlethwaite J R
Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Transplantation proceedings 1996;28(4):2136-7.
-
1996: Millis J M; Woodle E S; Piper J B; Bruce D S; Newell K A; Seaman D S; Baker A L; Hart J; Dasgupta K; Thistlethwaite J R
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
Transplantation 1996;61(9):1365-9.
-
1996: Kostelic J K; Piper J B; Leef J A; Lu C T; Rosenblum J D; Hackworth C; Kahn J; Thistlethwaite J R; Whitington P F
Angiographic selection criteria for living related liver transplant donors.
AJR. American journal of roentgenology 1996;166(5):1103-8.
-
1996: Woodle E S; Thistlethwaite J R; Haas M; Josephson M A; Newell K A; Bruce D S; Millis J M; Piper J B; Charette J I
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Transplantation proceedings 1996;28(2):998-9.
-
1996: Millis J M; Bruce D S; Newell K A; Piper J B; Woodle E S; Seaman D S; Baker A L; Hart J; Dasgupta K; Thistlethwaite J R
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Transplantation proceedings 1996;28(2):1014.
-
1995: Bruce D S; Newell K A; Woodle E S; Millis J M; Piper J B; Seaman D S; Huss E; Thistlethwaite J R
Late complications in kidney-pancreas transplant recipients.
Transplantation proceedings 1995;27(6):3118.
-
1995: Newell K A; Woodle E S; Millis J M; Piper J B; Huss E; Seaman D S; Bruce D S; Thistlethwaite J R
Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function.
Transplantation proceedings 1995;27(6):3002-3.
-
1995: Lenschow D J; Zeng Y; Hathcock K S; Zuckerman L A; Freeman G; Thistlethwaite J R; Gray G S; Hodes R J; Bluestone J A
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Transplantation 1995;60(10):1171-8.
-
1995: Jeyarajah D R; Kadakia R A; O'Toole K; Newell K A; Josephson M A; Spargo B H; Woodle E S; Thistlethwaite J R
Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.
Transplantation proceedings 1995;27(1):887-9.
-
1995: Zeng Y; Peterson L; Levisetti M; Torres M; Montag A; Thistlethwaite J R
Immunomodulation of human islets results in prolonged in vivo islet graft survival.
Transplantation proceedings 1995;27(1):611-2.
-
1995: Smith D M; Bluestone J A; Thistlethwaite J R; Woodle E S
Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction.
Transplantation proceedings 1995;27(1):395-7.
-
1995: Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite J R
Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
Transplantation proceedings 1995;27(1):176-7.
-
1995: Millis J M; Alonso E M; Piper J B; Bruce D S; Newell K A; Woodle E S; Baker A L; Whitington P F; Thistlethwaite J R
Liver transplantation at the University of Chicago.
Clinical transplants 1995;():187-97.
-
1994: Josephson M A; Spargo B; Hollandsworth D; Thistlethwaite J R
The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;24(5):873-8.
-
1994: Alegre M L; Peterson L J; Jeyarajah D R; Weiser M; Bluestone J A; Thistlethwaite J R
Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(6):2738-49.
-
1994: Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite J R; Bluestone J A
Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
Transplantation 1994;58(6):681-9.
-
1994: Smith D M; Bluestone J A; Jeyarajah D R; Newberg M H; Engelhard V H; Thistlethwaite J R; Woodle E S
Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(3):1054-67.
-
1994: Jeyarajah D R; Schmeisser F S; Kadakia R A; Thistlethwaite J R
Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
Transplantation proceedings 1994;26(3):1201-2.
-
1994: Alegre M L; Peterson L J; Xu D; Sattar H A; Jeyarajah D R; Kowalkowski K; Thistlethwaite J R; Zivin R A; Jolliffe L; Bluestone J A
A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
Transplantation 1994;57(11):1537-43.
-
1994: Zeng Y; Torres M A; Thistlethwaite J R; Montag A; Bluestone J A
Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody.
Transplantation proceedings 1994;26(3):1120.
-
1994: Jeyarajah D R; Schmeisser F S; Josephson M A; Sohn D G; Thistlethwaite J R
Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Transplantation proceedings 1994;26(2):771-3.
-
1994: Zeng Y; Torre M A; Karrison T; Thistlethwaite J R
The correlation between donor characteristics and the success of human islet isolation.
Transplantation 1994;57(6):954-8.
-
1994: Piper J B; Whitington P F; Woodle E S; Newell K A; Alonso E M; Thistlethwaite J R
Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S111-3.
-
1993: Whitington P F; Emond J C; Heffron T; Thistlethwaite J R
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1.
Lancet 1993;342(8874):779-80.
-
1993: O'Meara N M; Sturis J; Blackman J D; Byrne M M; Jaspan J B; Roland D C; Thistlethwaite J R; Polonsky K S
Oscillatory insulin secretion after pancreas transplant.
Diabetes 1993;42(6):855-61.
-
1993: Jeyarajah D R; Thistlethwaite J R
General aspects of cytokine-release syndrome: timing and incidence of symptoms.
Transplantation proceedings 1993;25(2 Suppl 1):16-20.
-
1993: Bluestone J A; Bruce D; Peterson L; Thistlethwaite J R; Josephson M; Zeng Y; Linsley P S; Lenschow D J
Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules.
Transplantation proceedings 1993;25(1 Pt 1):546-7.
-
1993: Bartosh S M; Aronson A J; Swanson-Pewitt E E; Thistlethwaite J R
OKT3 induction in pediatric renal transplantation.
Pediatric nephrology (Berlin, Germany) 1993;7(1):45-9.
-
1992: Vedantham S; Taylor F C; Yousefzadeh D K; Udekwu P; Thistlethwaite J R; Whitington P F
Abdominal pain in a young girl due to congenital stenosis of the common bile duct with mucus plug formation.
Journal of pediatric gastroenterology and nutrition 1992;15(4):440-3.
-
1992: Blackman J D; Polonsky K S; Jaspan J B; Sturis J; Van Cauter E; Thistlethwaite J R
Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.
Diabetes 1992;41(10):1346-54.
-
1992: George D L; Arnow P M; Fox A; Thistlethwaite J R; Emond J C; Broelsch C E; Whitington P F
Patterns of infection after pediatric liver transplantation.
American journal of diseases of children (1960) 1992;146(8):924-9.
-
1992: Lenschow D J; Zeng Y; Thistlethwaite J R; Montag A; Brady W; Gibson M G; Linsley P S; Bluestone J A
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
Science (New York, N.Y.) 1992;257(5071):789-92.
-
1992: Alegre M L; Collins A M; Pulito V L; Brosius R A; Olson W C; Zivin R A; Knowles R; Thistlethwaite J R; Jolliffe L K; Bluestone J A
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(11):3461-8.
-
1992: Woodle E S; Thistlethwaite J R; Jolliffe L K; Zivin R A; Collins A; Adair J R; Bodmer M; Athwal D; Alegre M L; Bluestone J A
Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(9):2756-63.
-
1992: Josephson M A; Schmeisser S; Sohn D; Buckingham F; Thistlethwaite J R
Rat to mouse pancreas xenografts: comparison to islet xenografts.
Transplantation proceedings 1992;24(2):653-4.
-
1992: Stevens L H; Emond J C; Piper J B; Heffron T G; Thistlethwaite J R; Whitington P F; Broelsch C E
Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors.
Transplantation 1992;53(2):396-9.
-
1992: Heffron T G; Emond J C; Whitington P F; Thistlethwaite J R; Stevens L; Piper J; Whitington S; Broelsch C E
Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts.
Transplantation 1992;53(2):391-5.
-
1992: Piper J B; Whitington P F; Woodle E S; Newell K A; Alonso E M; Emond J C; Heffron T G; Broelsch C E; Thistlethwaite J R
Pediatric liver transplantation at the University of Chicago Hospitals.
Clinical transplants 1992;():179-89.
-
1991: Broelsch C E; Whitington P F; Emond J C; Heffron T G; Thistlethwaite J R; Stevens L; Piper J; Whitington S H; Lichtor J L
Liver transplantation in children from living related donors. Surgical techniques and results.
Annals of surgery 1991;214(4):428-37; discussion 437-9.
-
1991: Woodle E S; Thistlethwaite J R; Ghobrial I A; Jolliffe L K; Stuart F P; Bluestone J A
OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
Transplantation 1991;52(2):354-60.
-
1991: Thistlethwaite J R; Emond J C; Heffron T G; Whitington P F; Black D D; Broelsch C E
Innovative use of organs for liver transplantation.
Transplantation proceedings 1991;23(4):2147-51.
-
1991: Woodle E S; Thistlethwaite J R; Jolliffe L K; Fucello A J; Stuart F P; Bluestone J A
Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
Transplantation 1991;52(2):361-8.
-
1991: Vogelbach P; Emond J C; Thistlethwaite J R; Broelsch C E
[Preservation of donor livers with University of Wisconsin solution]
Helvetica chirurgica acta 1991;58(1-2):159-61.
-
1991: Vogelbach P; Emond J C; Thistlethwaite J R; Broelsch C E
[Splitting liver transplantation. Orthotopic liver transplantation in two recipients with a single donor liver]
Helvetica chirurgica acta 1991;58(1-2):147-8.
-
1991: Woodle E S; Thistlethwaite J R; Emond J C; Whitington P F; Black D D; Aran P P; Baker A L; Stuart F P; Broelsch C E
OKT3 therapy for hepatic allograft rejection. Differential response in adults and children.
Transplantation 1991;51(6):1207-12.
-
1991: Whitington P F; Emond J C; Black D D; Whitington S H; Boone P; Smith C; Thistlethwaite J R; Broelsch C E
Indications for liver transplantation in pediatric patients.
Clinical transplantation 1991;5(2 part 2):155-60.
-
1991: Woodle E S; Thistlethwaite J R; Jolliffe L K; Ghobrial I; Fuccello A J; Stuart F P; Bluestone J A
T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies.
Transplantation proceedings 1991;23(1 Pt 1):81-2.
-
1991: Heimann P; Josephson M A; Fellner S K; Thistlethwaite J R; Stuart F P; Dasgupta A
Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
American journal of nephrology 1991;11(6):470-4.
-
1990: Ellenhorn J D; Woodle E S; Thistlethwaite J R; Bluestone J A
T lymphocyte activation following OKT3 treatment.
Current surgery 1990;47(6):458-9.
-
1990: Heffron T G; Gadowski G; Buckingham F; Salciunas P; Thistlethwaite J R; Stuart F P
Laser Doppler blood flow measurement as a predictor of viability of renal allografts.
Current surgery 1990;47(6):431-2.
-
1990: Ellenhorn J D; Woodle E S; Ghobreal I; Thistlethwaite J R; Bluestone J A
Activation of human T cells in vivo following treatment of transplant recipients with OKT3.
Transplantation 1990;50(4):608-12.
-
1990: Broelsch C E; Emond J C; Whitington P F; Thistlethwaite J R; Baker A L; Lichtor J L
Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants.
Annals of surgery 1990;212(3):368-75; discussion 375-7.
-
1990: Thistlethwaite J R; Heffron T G; Stevens L; Buckingham M; Stuart J K; Stuart F P
The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation.
Transplantation proceedings 1990;22(4):1897-8.
-
1990: Thistlethwaite J R; Emond J C; Woodle E S; Vogelbach P; Black D D; Whitington P F; Broelsch C E
Increased utilization of organ donors: transplantation of two recipients from single donor livers.
Transplantation proceedings 1990;22(4):1485-6.
-
1990: Woodle E S; Thistlethwaite J R; Emond J C; Whitington P F; Black D D; Aran P P; Baker A L; Stuart F P; Broelsch C E
OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.
Transplantation proceedings 1990;22(4):1765-6.
-
1990: Emond J C; Whitington P F; Thistlethwaite J R; Cherqui D; Alonso E A; Woodle I S; Vogelbach P; Busse-Henry S M; Zucker A R; Broelsch C E
Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting.
Annals of surgery 1990;212(1):14-22.
-
1990: Singer P A; Siegler M; Lantos J D; Emond J C; Whitington P F; Thistlethwaite J R; Broelsch C E
The ethical assessment of innovative therapies: liver transplantation using living donors.
Theoretical medicine 1990;11(2):87-94.
-
1990: Woodle E S; Thistlethwaite J R; Emond J C; Whitington P F; Vogelbach P; Yousefzadeh D K; Broelsch C E
Successful hepatic transplantation in congenital absence of recipient portal vein.
Surgery 1990;107(4):475-9.
-
1990: Rouch D A; Emond J C; Thistlethwaite J R; Mayes J T; Broelsch C E
Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver.
Surgery, gynecology & obstetrics 1990;170(3):239-44.
-
1989: Thistlethwaite J R; Heffron T G; Stuart J K; Buckingham M; Stuart F P
Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;14(5 Suppl 2):28-34.
-
1989: Emond J C; Mayes J T; Rouch D A; Thistlethwaite J R; Broelsch C E
Experience with radical resection in the management of proximal bile duct cancer.
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 1989;1(4):297-305; discussion 305-7.
-
1989: Singer P A; Siegler M; Whitington P F; Lantos J D; Emond J C; Thistlethwaite J R; Broelsch C E
Ethics of liver transplantation with living donors.
The New England journal of medicine 1989;321(9):620-2.
-
1989: Ellis J E; Lichtor J L; Feinstein S B; Chung M R; Polk S L; Broelsch C; Emond J; Thistlethwaite J R; Roizen M F
Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study.
Anesthesia and analgesia 1989;68(6):777-82.
-
1989: Thistlethwaite J R; Woodle E S; Mayes J T; Stuart J K; Heffron T G; Spargo B H; Stuart F P
Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
Transplantation proceedings 1989;21(1 Pt 2):1890-2.
-
1989: Woodle E S; Heffron T G; Stuart J K; Thistlethwaite J R; Stuart F P
Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Transplantation proceedings 1989;21(1 Pt 2):1641-2.
-
1989: Lloyd D M; Weiser M R; Kang R H; Buckingham M; Stuart F P; Thistlethwaite J R
Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation?
Transplantation proceedings 1989;21(1 Pt 1):482-3.
-
1989: Perdrizet G A; Heffron T G; Buckingham F C; Salciunas P J; Gaber A O; Stuart F P; Thistlethwaite J R
Stress conditioning: a novel approach to organ preservation.
Current surgery 1989;46(1):23-6.
-
1989: Lloyd D M; Cotler S J; Letai A G; Stuart F P; Thistlethwaite J R
Pancreas-graft immunogenicity and pretreatment with anti-class II monoclonal antibodies.
Diabetes 1989;38 Suppl 1():104-8.
-
1989: Broelsch E; Vogelbach P; Emond J C; Thistlethwaite J R; Woodle S A; Baker A L; Whitington P F
[Shunt surgery with reference to indications for liver transplantation]
Langenbecks Archiv für Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1989;():293-9.
-
1988: Rouch D A; Thistlethwaite J R; Lichtor L; Emond J C; Broelsch C E
Effect of massive transfusion during liver transplantation on rejection and infection.
Transplantation proceedings 1988;20(6):1135-7.
-
1988: Gaber A O; Thistlethwaite J R; Buckingham F C; Lloyd D M; Ramsy O; Stuart F P
Intermediate normothermic hemoperfusion of rat kidneys: functional aspects and a study into the effect of free radical scavengers.
Transplantation proceedings 1988;20(5):896-8.
-
1988: Gaber A O; Thistlethwaite J R; Busse-Henry S; Aboushloe M; Emond J; Rouch D; Broelsch C E
Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins.
Transplantation proceedings 1988;20(5):992-3.
-
1988: Thistlethwaite J R; Gaber A O; Stuart F P; Lloyd D W; Emond J; Rouch D; Broelsch C E
Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation.
Transplantation proceedings 1988;20(5):833-4.
-
1988: Broelsch C E; Emond J C; Thistlethwaite J R; Whitington P F; Zucker A R; Baker A L; Aran P F; Rouch D A; Lichtor J L
Liver transplantation, including the concept of reduced-size liver transplants in children.
Annals of surgery 1988;208(4):410-20.
-
1988: Lichtor J L; Emond J; Chung M R; Thistlethwaite J R; Broelsch C E
Pediatric orthotopic liver transplantation: multifactorial predictions of blood loss.
Anesthesiology 1988;68(4):607-11.
-
1988: Broelsch C E; Emond J C; Thistlethwaite J R; Rouch D A; Whitington P F; Lichtor J L
Liver transplantation with reduced-size donor organs.
Transplantation 1988;45(3):519-24.
-
1988: Mayes J T; Thistlethwaite J R; Stuart J K; Buckingham M R; Stuart F P
Reexposure to OKT3 in renal allograft recipients.
Transplantation 1988;45(2):349-53.
-
1988: Thistlethwaite J R; Stuart J K; Mayes J T; Gaber A O; Stuart F P
Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):94-8.
-
1988: Thistlethwaite J R; Stuart J K; Mayes J T; Gaber A O; Woodle S; Buckingham M R; Stuart F P
Complications and monitoring of OKT3 therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):112-9.
-
1987: Lloyd D M; Franklin W; Buckingham F; Buckingham M; Rizner J S; Stuart F P; Thistlethwaite J R
Ex vivo perfusion of the intact rat pancreas with anti-class II monoclonal antibody: labeling of dendritic cells.
Transplantation proceedings 1987;19(1 Pt 1):620-3.
-
1987: Thistlethwaite J R; Gaber A O; Haag B W; Aronson A J; Broelsch C E; Stuart J K; Stuart F P
OKT3 treatment of steroid-resistant renal allograft rejection.
Transplantation 1987;43(2):176-84.
-
1987: Gaber A O; Thistlethwaite J R; Haag B W; Stuart J; Mayes J; Fellner S; Stuart F P
Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
Transplantation proceedings 1987;19(1 Pt 3):1915-6.
-
1987: Gaber A O; Yang H C; Haag B W; Buckingham F C; Lloyd D M; Thistlethwaite J R; Stuart F P
Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys.
Transplantation proceedings 1987;19(1 Pt 2):1369-71.
-
1987: Stuart F P; Stuart J K; Thistlethwaite J R; Gaber A O; Mayes J
An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.
Transplantation proceedings 1987;19(1 Pt 3):1959-60.
-
1987: Thistlethwaite J R; Haag B W; Gaber A O; Stuart J K; Aronson A J; Mayes J T; Lloyd D M; Stuart F P
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.
Transplantation proceedings 1987;19(1 Pt 3):1901-4.
-
1987: Thistlethwaite J R; Buckingham M; Stuart J K; Gaber A O; Mayes J T; Stuart F P
T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.
Transplantation proceedings 1987;19(1 Pt 1):722-4.
-
1985: Thistlethwaite J R; Haag B W; Jones K W; Stuart J K; Stuart F P
Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.
Human immunology 1985;14(3):314-23.
Sign-in to see more